Trial intelligence / Profile preview

Myo-Inositol vs Myo-Inositol + Metformin in Overweight Women With PCOS

NCT07323589Phase 3Completed

Sponsor
PAEC General Hospital
Start
Jan 2025
Primary completion
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of myo-inositol, metformin in polycystic ovary syndrome (PCOS), sponsored by PAEC General Hospital. Started Jan 2025; status: completed.

02

Drugs

myo-inositolmetformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT07323589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07323589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call